iifl-logo

Elder Pharmaceuticals Ltd Cash Flow Statement

38
(4.97%)
Sep 12, 2016|03:28:30 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Elder Pharmaceuticals Ltd FINANCIALS

Y/e 31 Mar( In .Cr)Jun-2014Jun-2013Mar-2012

Profit before tax

-362.19

120.79

109.8

Depreciation

-29.15

-36.52

-27.63

Tax paid

-9.93

-21.96

-19.43

Working capital

-239.12

-156.42

Other operating items

Operating

-640.39

-94.11

Capital expenditure

-43.17

12.9

Free cash flow

-683.56

-81.21

Equity raised

1,514.36

1,334.71

Investing

-0.17

-17.19

Financing

471.63

809.65

Dividends paid

0

0

6.16

Net in cash

1,302.25

2,045.95

Elder Pharmaceuticals Ltd : related Articles

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.